High-Throughput Screening Assay for Inhibitors of TonB-Dependent Iron Transport

被引:8
|
作者
Hanson, Mathew [1 ]
Jordan, Lorne D. [1 ]
Shipelskiy, Yan [1 ]
Newton, Salete M. [1 ]
Klebba, Phillip E. [1 ]
机构
[1] Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall, Manhattan, KS 66502 USA
关键词
antibacterial drugs; cell-based assays; fluorescence methods; Gram-negative bacteria; iron; FERRIC ENTEROBACTIN; FEPA; MEMBRANE; BINDING; MOTION;
D O I
10.1177/1087057115613788
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The TonB-dependent Gram-negative bacterial outer membrane protein FepA actively transports the siderophore ferric enterobactin (FeEnt) into the periplasm. We developed a high-throughput screening (HTS) assay that observes FeEnt uptake through FepA in living Escherichia coli, by monitoring fluorescence quenching that occurs upon binding of FeEnt, and then unquenching as the bacteria deplete it from solution by transport. We optimized the labeling and spectroscopic methods to screen for inhibitors of TonB-dependent iron uptake through the outer membrane. The assay works like a molecular switch that is on in the presence of TonB activity and off in its absence. It functions in 96-well microtiter plates, in a variety of conditions, with Z factors of 0.8-1.0. TonB-dependent iron transport is energy dependent, and the inhibitory effects of the metabolic inhibitors carbonyl cyanide m-chlorophenylhydrazone, 2,4-dinitrophenol, azide, cyanide, and arsenate on FeEnt uptake were readily detected by the assay. Because iron acquisition is a determinant of bacterial pathogenesis, HTS with this method may identify inhibitors that block TonB function and constitute novel therapeutics against infectious disease caused by Gram-negative bacteria.
引用
收藏
页码:316 / 322
页数:7
相关论文
共 50 条
  • [31] High-throughput screening: advances in assay technologies
    Sittampalam, GS
    Kahl, SD
    Janzen, WP
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (03) : 384 - 391
  • [32] High-throughput screening - Free your assay
    Kirkpatrick, P
    NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (07) : 553 - 553
  • [33] TonB-dependent transport by the gut microbiota: novel aspects of an old problem
    Bolam, David N.
    van den Berg, Bert
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2018, 51 : 35 - 43
  • [34] High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors
    El Qaidi, Samir
    Zhu, Congrui
    McDonald, Peter
    Roy, Anuradha
    Maity, Pradip Kumar
    Rane, Digamber
    Perera, Chamani
    Hardwidge, Philip R.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2018, 8
  • [35] High-throughput screening for inhibitors of signaling pathways
    Shoemaker, RH
    BRITISH JOURNAL OF CANCER, 2001, 85 : 6 - 6
  • [36] High-throughput screening for human galactokinase inhibitors
    Wierenga, Klaas J.
    Lai, Kent
    Buchwald, Peter
    Tang, Manshu
    JOURNAL OF BIOMOLECULAR SCREENING, 2008, 13 (05) : 415 - 423
  • [37] High-Throughput Screening for the Discovery of Enzyme Inhibitors
    Lloyd, Matthew D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 10742 - 10772
  • [38] Development of a High-Content High-Throughput Screening Assay for the Discovery of ATM Signaling Inhibitors
    Bardelle, Catherine
    Boros, Joanna
    JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (07) : 912 - 920
  • [39] TonB-dependent systems of uropathogenic Escherichia coli:: Aerobactin and heme transport and TonB are required for virulence in the mouse
    Torres, AG
    Redford, P
    Welch, RA
    Payne, SM
    INFECTION AND IMMUNITY, 2001, 69 (10) : 6179 - 6185
  • [40] Identification of Inhibitors of a Bacterial Sigma Factor Using a New High-Throughput Screening Assay
    El-Mowafi, S. A.
    Sineva, E.
    Alumasa, J. N.
    Nicoloff, H.
    Tomsho, J. W.
    Ades, S. E.
    Keiler, K. C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (01) : 193 - 205